<?xml version="1.0" encoding="UTF-8"?><experiments api-version="3" api-revision="091015" version="3.0" revision="091015" total="3" total-samples="37" total-assays="37"><experiment><id>522484</id><accession>E-GEOD-19280</accession><secondaryaccession>GSE19280</secondaryaccession><name>Transcription profiling by array of normal pancreas, primary pancreatic ductal adenocarcinoma (PDAC), normal liver, and pancreatic liver metastases using the Affymetrix HG-U133B array</name><releasedate>2013-08-15</releasedate><lastupdatedate>2015-04-30</lastupdatedate><organism>Homo sapiens</organism><experimenttype>transcription profiling by array</experimenttype><description><id/><text>Pancreatic cancer is a devastating disease with both local invasion and distant metastasis. Identifying the genes expressed in liver metastases and signatures of metastatic progression would therefore be of particular importance as they could aid in both recurrence prediction as well as representing novel therapeutic targets.  Keywords: Gene expression profiling We have performed microarray gene expression analysis of normal pancreas, primary pancreatic ductal adenocarcinoma (PDAC), normal liver and pancreatic liver metastases to identify potential therapeutic targets.</text></description><provider><contact>Sayka Barry</contact><role/><email/></provider><provider><contact>Claude Chelala</contact><role>submitter</role><email>c.chelala@qmul.ac.uk</email></provider><provider><contact>Claude Chelala</contact><role/><email/></provider><provider><contact>Tatjana Crnogorac-Jurcevic</contact><role/><email/></provider><bibliography><accession>23007696</accession><authors>Barry S, Chelala C, Lines K, Sunamura M, Wang A, Marelli-Berg FM, Brennan C, Lemoine NR, Crnogorac-Jurcevic T</authors><title>S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells.</title><doi>10.1007/s10585-012-9532-y</doi></bibliography><samplecharacteristic><category>disease</category><value>normal</value><value>pancreatic ductal adenocarcinoma liver metastasis</value><value>primary pancreatic ductal adenocarcinoma</value></samplecharacteristic><samplecharacteristic><category>organism</category><value>Homo sapiens</value></samplecharacteristic><samplecharacteristic><category>organism part</category><value>liver</value><value>pancreas</value></samplecharacteristic><experimentalvariable><name>disease</name><value>normal</value><value>pancreatic ductal adenocarcinoma liver metastasis</value><value>primary pancreatic ductal adenocarcinoma</value></experimentalvariable><experimentalvariable><name>organism part</name><value>liver</value><value>pancreas</value></experimentalvariable><arraydesign><id>10982</id><accession>A-AFFY-34</accession><name>Affymetrix GeneChip Human Genome HG-U133B [HG-U133B]</name><count>15</count><legacy_id>212395355</legacy_id></arraydesign><protocol><id>1128208</id><accession>P-GSE19280-6</accession></protocol><protocol><id>1128207</id><accession>P-GSE19280-1</accession></protocol><protocol><id>1128209</id><accession>P-GSE19280-5</accession></protocol><protocol><id>1128210</id><accession>P-GSE19280-4</accession></protocol><protocol><id>1128212</id><accession>P-GSE19280-3</accession></protocol><protocol><id>1128211</id><accession>P-GSE19280-2</accession></protocol><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>15</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>15</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>15</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>15</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>15</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>15</bioassays><isderived>0</isderived></bioassaydatagroup></experiment><experiment><id>522485</id><accession>E-GEOD-19279</accession><secondaryaccession>GSE19279</secondaryaccession><name>Transcription profiling by array of normal pancreas, primary pancreatic ductal adenocarcinoma (PDAC), normal liver, and pancreatic liver metastases using the Affymetrix HG-U133A array</name><releasedate>2013-08-15</releasedate><lastupdatedate>2015-04-30</lastupdatedate><organism>Homo sapiens</organism><experimenttype>transcription profiling by array</experimenttype><description><id/><text>Pancreatic cancer is a devastating disease with both local invasion and distant metastasis. Identifying the genes expressed in liver metastases and signatures of metastatic progression would therefore be of particular importance as they could aid in both recurrence prediction as well as representing novel therapeutic targets.  Keywords: Gene expression profiling We have performed microarray gene expression analysis of normal pancreas, primary pancreatic ductal adenocarcinoma (PDAC), normal liver, and pancreatic liver metastases to identify potential therapeutic targets.</text></description><provider><contact>Claude Chelala</contact><role/><email/></provider><provider><contact>Sayka Barry</contact><role/><email/></provider><provider><contact>Tatjana Crnogorac-Jurcevic</contact><role/><email/></provider><provider><contact>Claude Chelala</contact><role>submitter</role><email>c.chelala@qmul.ac.uk</email></provider><bibliography><accession>23007696</accession><authors>Barry S, Chelala C, Lines K, Sunamura M, Wang A, Marelli-Berg FM, Brennan C, Lemoine NR, Crnogorac-Jurcevic T</authors><title>S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells.</title><doi>10.1007/s10585-012-9532-y</doi></bibliography><samplecharacteristic><category>disease</category><value>normal</value><value>pancreatic ductal adenocarcinoma liver metastasis</value><value>primary pancreatic ductal adenocarcinoma</value></samplecharacteristic><samplecharacteristic><category>organism</category><value>Homo sapiens</value></samplecharacteristic><samplecharacteristic><category>organism part</category><value>liver</value><value>pancreas</value></samplecharacteristic><experimentalvariable><name>disease</name><value>normal</value><value>pancreatic ductal adenocarcinoma liver metastasis</value><value>primary pancreatic ductal adenocarcinoma</value></experimentalvariable><experimentalvariable><name>organism part</name><value>liver</value><value>pancreas</value></experimentalvariable><arraydesign><id>11043</id><accession>A-AFFY-33</accession><name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name><count>15</count><legacy_id>302382080</legacy_id></arraydesign><protocol><id>1128216</id><accession>P-GSE19279-4</accession></protocol><protocol><id>1128215</id><accession>P-GSE19279-5</accession></protocol><protocol><id>1128214</id><accession>P-GSE19279-6</accession></protocol><protocol><id>1128213</id><accession>P-GSE19279-1</accession></protocol><protocol><id>1128218</id><accession>P-GSE19279-2</accession></protocol><protocol><id>1128217</id><accession>P-GSE19279-3</accession></protocol><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>15</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>15</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>15</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>15</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>15</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>15</bioassays><isderived>0</isderived></bioassaydatagroup></experiment><experiment><id>525920</id><accession>E-GEOD-19278</accession><secondaryaccession>GSE19278</secondaryaccession><name>S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells [HG-U133_Plus_2]</name><releasedate>2013-08-15</releasedate><lastupdatedate>2015-08-06</lastupdatedate><organism>Homo sapiens</organism><experimenttype>transcription profiling by array</experimenttype><description><id/><text>We and others have shown that S100P is highly upregulated during the progression of pancreatic cancer. We used microarrays to look at the target genes regulated by S100P in the pancreatic cancer cell line Panc1.  Keywords: Gene overexpression We generated stable cell lines by introducing control vector pcDNA3.1/V5-His or S100P-overexpressing vector pcDNA3.1/S100P-V5-His into the pancreatic cancer cell line Panc1, single cell clones were then isolated. RNA was extracted and hybridized on Affymetrix microarrays. We looked for new target genes regulated by S100P.</text></description><provider><contact>Tatjana Crnogorac-Jurcevic</contact><role/><email/></provider><provider><contact>Claude Chelala</contact><role>submitter</role><email>c.chelala@qmul.ac.uk</email></provider><provider><contact>Sayka Barry</contact><role/><email/></provider><bibliography><accession>23007696</accession><authors>Barry S, Chelala C, Lines K, Sunamura M, Wang A, Marelli-Berg FM, Brennan C, Lemoine NR, Crnogorac-Jurcevic T</authors><title>S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells.</title><doi>10.1007/s10585-012-9532-y</doi></bibliography><samplecharacteristic><category>cell line</category><value>Panc1</value></samplecharacteristic><samplecharacteristic><category>disease</category><value>pancreatic cancer</value></samplecharacteristic><samplecharacteristic><category>genotype</category><value>control</value><value>S100P overexpressing</value></samplecharacteristic><samplecharacteristic><category>organism</category><value>Homo sapiens</value></samplecharacteristic><experimentalvariable><name>genotype</name><value>control</value><value>S100P overexpressing</value></experimentalvariable><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>7</count><legacy_id>405156763</legacy_id></arraydesign><protocol><id>1145064</id><accession>P-GSE19278-1</accession></protocol><protocol><id>1145069</id><accession>P-GSE19278-2</accession></protocol><protocol><id>1145068</id><accession>P-GSE19278-3</accession></protocol><protocol><id>1145070</id><accession>P-GSE19278-4</accession></protocol><protocol><id>1145067</id><accession>P-GSE19278-5</accession></protocol><protocol><id>1145066</id><accession>P-GSE19278-6</accession></protocol><protocol><id>1145065</id><accession>P-GSE19278-7</accession></protocol><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>7</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>7</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>7</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>7</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>7</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>7</bioassays><isderived>0</isderived></bioassaydatagroup></experiment></experiments>